INVG yields 3.51% · MRK yields 2.76%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, INVG + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of INVG + MRK for your $10,000?
INVG seeks to outperform the Bloomberg U.S. Corporate Index through a systematic multi-factor approach. While aiming for similar exposures to its benchmark, the fund targets more liquid, investment grade corporate bonds of various maturities that include those issued by both US and non-US companies. The fund analyzes various factors (e.g., value, quality, momentum, and fundamentals), captured through proprietary fair value models that measure default risk and market momentum. The strategy aims for attractive risk/return opportunities while limiting tracking err by managing country, sector, issuer exposure, liquidity, interest rate, and credit spread risks. As an actively managed fund, the portfolio manager has full discretion to adjust the portfolio at any time. INVG may also invest in derivatives and other ETFs, as well as US Treasury and money market funds or instruments.
Full INVG Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.